title: Authors' reply to Minisola and colleagues, Kausar, and Sharvill.
authors.affiliation: Division of Endocrinology, Diabetes, Nutrition, and Metabolism, Mayo Clinic, Rochester, MN 55905, USA kennel.kurt@mayo.edu.
authors.forename: Kurt A
authors.initials: KA
authors.lastname: Kennel
authors.affiliation: Division of Endocrinology, Diabetes, Nutrition, and Metabolism, Mayo Clinic, Rochester, MN 55905, USA.
authors.forename: Spyridoula
authors.initials: S
authors.lastname: Maraka
mesh_terms: D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D004164:Diphosphonates / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D010024:Osteoporosis / Q000188:drug therapy* / Q000517:prevention & control*
chemical_list: D050071:Bone Density Conservation Agents; D004164:Diphosphonates